Alan Meds vs Claya
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alan Meds
Best for budget-conscious shoppersStarting at $99/mo
Claya
Best for Patients seeking a compounded GLP-1 platform with named clinician leadership and named pharmacy partners who want both injectable and oral-tablet form factors, and who are comfortable with the standard 503A-compounded supply chain.Starting at $179/mo
Side-by-Side Comparison
| Feature | Alan Meds | Claya |
|---|---|---|
| Overall Score | ✓7.7/10 | 7.0/10 |
| Starting Price | ✓$99/mo | $179/mo |
| Editorial Rating | ✓3.9 ★ /5 | 3.5 ★ /5 |
| Features | 5 features | ✓8 features |
| States Available | ✓46 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alan Meds
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
Claya
Pros
- ✓Two named licensed clinicians (Habashy NMD MS and Barber MD PhD) — rare transparency for a compounded-GLP-1 platform
- ✓Two named 503A-pattern pharmacy partners with full addresses (RedRock UT + Healthware KY)
- ✓Both injectable AND oral-tablet compounded formulations offered for both semaglutide and tirzepatide
- ✓Weight-loss money-back guarantee published on homepage
- ✓Free expedited shipping included in monthly price
Cons
- ✗States-served list NOT disclosed on homepage or FAQ — buyers must check at checkout
- ✗LegitScript certification status NOT displayed on homepage
- ✗Corporate legal entity (LLC/Inc/PC) NOT disclosed on site or in privacy policy
- ✗Compounded oral tablets are an aggressive form factor — efficacy data vs injectable semaglutide is weaker (no STEP-equivalent oral compounded trials)
- ✗Tiered pricing structure (intro vs refill) creates first-month price advantage that disappears at refill
Our Verdict
Alan Meds edges out Claya with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. Claya remains a solid alternative, especially if you're looking for Patients seeking a compounded GLP-1 platform with named clinician leadership and named pharmacy partners who want both injectable and oral-tablet form factors, and who are comfortable with the standard 503A-compounded supply chain..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.